menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Addressing Hyporesponsiveness to Erythropoetic Therapy

close
Addressing Hyporesponsiveness to Erythropoetic Therapy
Restart
Resume
Read full article
Choose a format
Media formats available:
Details
Presenters
Comments
  • Overview

    How can we optimize erythropoetic therapy in patients with anemia of chronic kidney disease? How widespread is the problem of hyporesponsiveness to erythropoetic-stimulating agents? Dr. Sarah Tomasello, clinical associate professor at the Ernest Mario School of Pharmacy at Rutgers, the State University of New Jersey, and a clinical specialist in nephrology at Robert Wood Johnson University Hospital in New Jersey, joins host Dr. Charles Turck.

Facebook Comments

Recommended
Details
Presenters
Comments
  • Overview

    How can we optimize erythropoetic therapy in patients with anemia of chronic kidney disease? How widespread is the problem of hyporesponsiveness to erythropoetic-stimulating agents? Dr. Sarah Tomasello, clinical associate professor at the Ernest Mario School of Pharmacy at Rutgers, the State University of New Jersey, and a clinical specialist in nephrology at Robert Wood Johnson University Hospital in New Jersey, joins host Dr. Charles Turck.

Facebook Comments

LIVE ON REACHMD RADIOBack to live radio

Loading...

Programs 11/23/20